Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevinkumar Kansagra

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Lancet. Infectious Diseases|June 1, 2022
Effect of novel antimalarial ZY-19489 on Plasmodium falciparum viability in a volunteer infection studyGeorges F R Radohery, Jeremy Gower, Bridget E Barber, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 26, 2026
Saroglitazar 4 Mg in Metabolic Dysfunction-Associated Steatotic Liver Disease: 24-Week Results From Phase 4 StudyArun Sanyal, Soham Doshi, Nitin Behl, et al.
Lancet (London, England)|April 3, 2022
Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in IndiaAkash Khobragade, Suresh Bhate, Vijendra Ramaiah, et al.
American Journal of Nephrology|April 24, 2022
Desidustat in Anemia due to Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-D)Sishir Gang, Prakash Khetan, Deepak Varade, et al.
Eclinicalmedicine|July 26, 2021
Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in IndiaTaufik Momin, Kevinkumar Kansagra, Hardik Patel, et al.
American Journal of Nephrology|April 24, 2022
Desidustat in Anemia due to Non-Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-ND)Dhananjai Agrawal, Deepak Varade, Hardik Shah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2020
A Phase 3, Randomized, Open-label, Noninferiority Trial Evaluating Anti-Rabies Monoclonal Antibody Cocktail (TwinrabTM) Against Human Rabies Immunoglobulin (HRIG)Kevinkumar Kansagra, Deven Parmar, Sanjeev Kumar Mendiratta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 4, 2020
Reply to Agrawal and KumarKevinkumar Kansagra, Deven Parmar, Sanjeev Kumar Mendiratta, et al.
Viruses|September 27, 2025
Immunogenicity and Safety Results of a Randomized, Three-Arm, Phase IV Clinical Trial of Concomitant Administration of Typhoid Vi Conjugate Vaccine with Measles and Rubella Vaccine in Healthy InfantsSonga Narayana Rao, Deepali Ambike, Mahantesh Patil, et al.
The Lancet. Infectious Diseases|March 5, 2022
Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection studyBridget E Barber, Melissa Fernandez, Hardik Babubhai Patel, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Lancet. Infectious Diseases|June 1, 2022
Effect of novel antimalarial ZY-19489 on Plasmodium falciparum viability in a volunteer infection studyGeorges F R Radohery, Jeremy Gower, Bridget E Barber, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 26, 2026
Saroglitazar 4 Mg in Metabolic Dysfunction-Associated Steatotic Liver Disease: 24-Week Results From Phase 4 StudyArun Sanyal, Soham Doshi, Nitin Behl, et al.
Lancet (London, England)|April 3, 2022
Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in IndiaAkash Khobragade, Suresh Bhate, Vijendra Ramaiah, et al.
American Journal of Nephrology|April 24, 2022
Desidustat in Anemia due to Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-D)Sishir Gang, Prakash Khetan, Deepak Varade, et al.
Eclinicalmedicine|July 26, 2021
Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in IndiaTaufik Momin, Kevinkumar Kansagra, Hardik Patel, et al.
American Journal of Nephrology|April 24, 2022
Desidustat in Anemia due to Non-Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-ND)Dhananjai Agrawal, Deepak Varade, Hardik Shah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2020
A Phase 3, Randomized, Open-label, Noninferiority Trial Evaluating Anti-Rabies Monoclonal Antibody Cocktail (TwinrabTM) Against Human Rabies Immunoglobulin (HRIG)Kevinkumar Kansagra, Deven Parmar, Sanjeev Kumar Mendiratta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 4, 2020
Reply to Agrawal and KumarKevinkumar Kansagra, Deven Parmar, Sanjeev Kumar Mendiratta, et al.
Viruses|September 27, 2025
Immunogenicity and Safety Results of a Randomized, Three-Arm, Phase IV Clinical Trial of Concomitant Administration of Typhoid Vi Conjugate Vaccine with Measles and Rubella Vaccine in Healthy InfantsSonga Narayana Rao, Deepali Ambike, Mahantesh Patil, et al.
The Lancet. Infectious Diseases|March 5, 2022
Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection studyBridget E Barber, Melissa Fernandez, Hardik Babubhai Patel, et al.
Pageof 3